Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.

Division of Infectious Diseases, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; Department of Organismic and Evolutionary Biology, Center for Systems Biology, Harvard University, Cambridge, MA, USA; The Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

[1]  N. Schork,et al.  Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium , 2012, Antimicrobial Agents and Chemotherapy.

[2]  R. Humphries,et al.  De Novo Daptomycin-Nonsusceptible Enterococcal Infections , 2012, Emerging infectious diseases.

[3]  R. Humphries,et al.  Case-Control Study Comparing De Novo and Daptomycin-Exposed Daptomycin-Nonsusceptible Enterococcus Infections , 2012, Antimicrobial Agents and Chemotherapy.

[4]  G. Weinstock,et al.  Genetic basis for in vivo daptomycin resistance in enterococci. , 2011, The New England journal of medicine.

[5]  M. Gilmore,et al.  Genetic Basis for Daptomycin Resistance in Enterococci , 2011, Antimicrobial Agents and Chemotherapy.

[6]  R. Humphries,et al.  Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Michael Heung,et al.  Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[8]  Steven D. Brown,et al.  Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. , 2000, Diagnostic microbiology and infectious disease.

[9]  L. Nilsson,et al.  Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs , 1991, Antimicrobial Agents and Chemotherapy.

[10]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[11]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .